Arizona State Retirement System’s Soleno Therapeutics SLNO Stock Holding History

Arizona State Retirement System’s Portfolio SLNO Stock Details SLNO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-12,540	Closed	-$420K	–	2116
2026 Q1	$420K	Sell	12,540 -89	-0.7%	-$3.49K	﹤0.01%	1553
2025 Q4	$585K	Buy	12,629 +948	+8%	+$52K	﹤0.01%	1388
2025 Q3	$790K	Buy	11,681 +2,173	+23%	+$161K	﹤0.01%	1260
2025 Q2	$797K	Buy	9,508 +2,128	+29%	+$159K	﹤0.01%	1225
2025 Q1	$527K	Buy	7,380 +620	+9%	+$30.2K	﹤0.01%	1386
2024 Q4	$304K	Buy	6,760 +1,454	+27%	+$75.3K	﹤0.01%	1751
2024 Q3	$268K	Buy	+5,306	New	+$254K	﹤0.01%	1827

Arizona State Retirement System's SLNO Position: Q2 2026 in Review

Arizona State Retirement System sold out of Soleno Therapeutics (SLNO) in Q2 2026, closing a stake of 12,540 shares — an estimated $420K sold.

Arizona State Retirement System first reported a position in SLNO in Q3 2024 and held it in 7 quarters. The position peaked at $797K in Q2 2025. 0 funds tracked by Wall St. Rank hold SLNO as of Q2 2026.

Arizona State Retirement System reported no remaining Soleno Therapeutics position as of Q2 2026 after selling out during the quarter.
Arizona State Retirement System sold 12,540 Soleno Therapeutics shares in Q2 2026, an estimated $420K.
Arizona State Retirement System first reported a position in Soleno Therapeutics in Q3 2024 and held it in 7 quarters.
Arizona State Retirement System's Soleno Therapeutics position peaked at $797K in Q2 2025.
0 funds tracked by Wall St. Rank held Soleno Therapeutics as of Q2 2026.

Based on Arizona State Retirement System's 13F filing for Q2 2026, filed 7 Aug 2026.